GLAND PHARMA LTD
Overview
GLAND PHARMA LTD is an active pharmaceutical ingredient (API) supplier with 69 active FDA Type II Drug Master Files, covering ACETAZOLAMIDE; ARGATROBAN MONOHYDRATE (PROCESS-II); ARGATROBAN MONOHYDRATE USP; ARIPIPRAZOLE LAUROXIL – STERILE; ARIPIPRAZOLE MONOHYDRATE – STERILE; ATRACURIUM BESYLATE USP.
Core services & business areas
Active ingredients with DMF or CEP filings
Substances for which GLAND PHARMA LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
GLAND PHARMA LTD holds 69 active (69 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- PRALATREXATEActive2025-09-29
- ISAVUCONAZONIUM SULFATEActive2025-06-13
- DANTROLENE SODIUMActive2024-03-29
- LEVOCARNITINEActive2023-11-27
- FOSAPREPITANT DIMEGLUMINEActive2023-09-29
- EPINEPHRINE (LOW EPIMER)Active2023-09-27
- MANGANESE SULFATEActive2022-12-30
- CUPRIC SULFATEActive2022-12-23
- LINEZOLIDActive2022-11-30
- ACETAZOLAMIDEActive2022-10-31
- CYSTEAMINE HYDROCHLORIDEActive2022-08-30
- SELENIOUS ACIDActive2022-08-24
- CHLOROTHIAZIDEActive2022-06-30
- REGADENOSON (PROCESS – II)Active2022-06-24
- PROTAMINE SULFATEActive2021-12-29
- ARIPIPRAZOLE LAUROXIL – STERILEActive2021-12-22
- PROCAINAMIDE HYDROCHLORIDEActive2021-10-30
- ARIPIPRAZOLE MONOHYDRATE – STERILEActive2021-09-30
- DIPHENHYDRAMINE HYDROCHLORIDEActive2021-06-30
- NETARSUDIL DIMESYLATEActive2021-06-17
- KETAMINE HYDROCHLORIDEActive2020-12-30
- EPINEPHRINEActive2020-12-16
- FOMEPIZOLEActive2020-11-30
- EDARAVONEActive2020-08-20
- ZINC SULFATE HEPTAHYDRATEActive2020-06-30
- LACOSAMIDEActive2020-04-29
- ERYTHROMYCIN LACTOBIONATEActive2019-12-31
- CISATRACRIUM BESYLATEActive2019-12-26
- TIGECYCLINE [PROCESS – II]Active2019-12-04
- SUGAMMADEX SODIUMActive2019-10-31
- ETOMIDATEActive2019-09-30
- FLUPHENAZINE DECANOATEActive2019-05-31
- FOSPHENYTOIN SODIUMActive2019-04-29
- ISOPROTERENOL HYDROCHLORIDEActive2019-02-28
- DOXYCYCLINE HYCLATE USPActive2018-09-28
- GLATIRAMER ACETATEActive2018-09-12
- ERTAPENEM SODIUMActive2018-01-12
- NEOSTIGMINE METHYLSULFATEActive2017-10-31
- PALIPERIDONE PALMITATE STERILEActive2017-10-13
- CASPOFUNGIN ACETATEActive2017-07-21
- PLERIXAFORActive2017-04-26
- ZIPRASIDONE MESILATE TRIHYDRATEActive2016-09-30
- BETAMETHASONE ACETATE USP STERILEActive2016-08-01
- TIGECYCLINE [MANUFACTURING SITE - II]Active2015-09-30
- FOSCARNET SODIUM USPActive2015-09-28
- FULVESTRANT USPActive2015-09-28
- CISATRACURIUM BESYLATE [PROCESS-II]Active2015-09-24
- IRON SUCROSE COMPLEXActive2015-08-31
- ATRACURIUM BESYLATE USP [PROCESS-II]Active2015-08-28
- LEVOTHYROXINE SODIUM USPActive2015-07-27
Showing the 50 most relevant of 69 Drug Master Files (active first). The full list is in the FDA DMF list.
Registered manufacturing sites (4)
Physical sites registered with the US FDA and resolved to GLAND PHARMA LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
31 FDA enforcement records linked to this company.
- 4832024-07-25
Procedures not in writing, fully followed
- 4832024-07-25
Record maintenance 1 year (except exempt OTC)
- 4832023-07-14
Complete test data included in records
- 4832019-11-07
Representative Samples
- 4832019-11-07
Scientifically sound laboratory controls
- 4832019-11-07
Written record of investigation incomplete
- 4832019-11-07
Equipment for Environmental Control
- 4832019-11-01
Written record of investigation incomplete
- 4832019-11-01
Validation lacking for sterile drug products
- 4832019-05-16
Written procedures lacking for use of pesticides etc.
- 4832019-05-16
Scientifically sound laboratory controls
- 4832019-05-16
Written procedures fail to include
- 4832019-05-16
Cleaning SOPs/schedules
- 4832019-05-16
Written record of investigation incomplete
- 4832019-05-16
Environmental Monitoring System
- 4832019-05-16
Product flow through building is inadequate
- 4832018-02-23
Training , Education , Experience overall
- 4832018-02-23
Procedures for sterile drug products
- 4832018-02-23
In-process conformity - examination, sample testing
- 4832018-02-23
Complaint Handling Procedure
- 4832012-09-07
Investigations of discrepancies, failures
- 4832012-09-07
Control procedures to monitor and validate performance
- 4832012-09-07
Training , Education , Experience overall
- 4832012-09-07
Contamination, chemical or physical change, deterioration
- 4832012-09-07
Complete test data included in records
- 4832012-09-07
Protective Apparel Not Worn
- 4832012-09-07
Calibration/Inspection/Checking not done
- 4832012-09-07
Written program not followed
- 4832012-09-07
Written sanitation procedures not followed
- 4832012-09-07
Drug products-sampling procedures/specifications
- 4832012-09-07
Procedures for sterile drug products
Is this GLAND PHARMA LTD?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.